GlassScriptPhysician profile
Xiao Jun Weng
NPI 1407219371
$8,002.66
in general payments reported to CMS, 2019-2025
41 companies · $2,734 in 2025
The $2,734 reported for 2025 was more than what 78% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $23.49 · 2021: $186 · 2022: $864 · 2023: $1,811 · 2024: $2,259 · 2025: $2,734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,644 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,643.95 |
| Education | $159.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,400.74 | 2022-2025 | Botox, Qulipta, Ubrelvy |
| Sk Life Science, INC. | $850.45 | 2022-2025 | Xcopri |
| Argenx US, INC. | $674.63 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Ucb, INC. | $467.56 | 2023-2025 | Rystiggo, Briviact, Nayzilam |
| Alexion Pharmaceuticals, INC. | $439.74 | 2023-2025 | Ultomiris |
| Neurocrine Biosciences, INC. | $436.89 | 2022-2025 | Ingrezza, Ongentys |
| Lilly USA, LLC | $309.80 | 2022-2025 | Kisunla, Amyvid |
| Allergan, INC. | $168.61 | 2021-2022 | |
| Mdd US Operations, LLC | $158.84 | 2022-2025 | Gocovri |
| Emd Serono, INC. | $150.51 | 2022-2025 | Mavenclad |
| Lundbeck LLC | $146.86 | 2023-2025 | Vyepti |
| Teva Pharmaceuticals USA, INC. | $134.63 | 2024-2025 | Austedo Xr, Austedo Xr |
| Pfizer INC. | $130.28 | 2023-2025 | |
| Eisai INC. | $130.16 | 2023-2025 | |
| Genentech USA, INC. | $125.25 | 2019 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiao Jun Weng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.